Detection of chromosome aberrations by iFISH in multiple myeloma and their clinical significance
Shan Meng,Wanhong Zhao,Yun Yang,Wanggang Zhang,Xingmei Cao,Longjin Zhang,Xin Meng,Wei Tian
DOI: https://doi.org/10.3969/j.issn.1672-4992.2018.03.029
2018-01-01
Journal of Modern Oncology
Abstract:Objective:To detect the chromosome aberrations in multiple myeloma (MM)patients using interphase fluorescence in situ hybridization (iFISH),and to explore their clinical significance and prognostic value. Methods:94 newly diagnosed MM patients were enrolled and iFISH panel probes of IGH,DLEU/ RB1,p53 and 1q21 were ap-plied to detect 14q32 translocation,del(13q14),del(17p13),and 1q21 application,respectively. The thresholds were established using 15 patients without hematopoietic malignancies. Results:A total of 74 patients of the whole 94 pa-tients (78. 72%)exhibited abnormal iFISH results. del(17p13)had the highest occurrence rate with the percentage of 60. 81%(45 / 74),followed by 1q21 application (59. 46%,44 / 74),14q32 translocation (41. 89%,31 / 74)and del(13q14)(37. 84%,28 / 74). It showed that del(17p13)was related with platelet count,albumin and globulin lev-els,14q32 translocation was related with albumin and myeloma cell burden,del(13q14)exhibited a correlation with hemoglobin,erythrocyte sedimentation rate,albumin and globulin levels,while 1q21 application did not show any rela-tions with these clinicopathological parameters. When patients were grouped by the therapeutic regimen,it showed that those whose iFISH were positive had worse treatment responses in VAD group compared with those negative,whereas it did not show any differences in bortezomib group. Moreover,14q32 translocation was shown to related with patients'o-verall survival,and del(17p13)was predicted to be independently associated with patients' overall survival and progres-sion free survival. Conclusion:Chromosome aberrations exist in majority of myeloma patients with high occurrence rate of del(17p13),1q21 application and 14q32 translocation,which indicated unfavorable clinical features and poor outcome.